• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 594-608 of 973 results

1146 Exhibit: Exhibit 1146 KDOQI 2007

Document IPR2023-00724, No. 1146 Exhibit - Exhibit 1146 KDOQI 2007 (P.T.A.B. May. 22, 2024)

cite Cite Document

2396 Exhibit: EX2396 US Food Drug Administration, DrugsFDA, Byetta®

Document IPR2023-00724, No. 2396 Exhibit - EX2396 US Food Drug Administration, DrugsFDA, Byetta® (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2380 Exhibit: EX2380 Mayo Clinic, “A1C test,” httpswwwmayoclinicorgtests procedu...

Document IPR2023-00724, No. 2380 Exhibit - EX2380 Mayo Clinic, “A1C test,” httpswwwmayoclinicorgtests procedures a1c testaboutpac 20384643, last updated Dec 1, 2022 (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2379 Exhibit: EX2379 Novo Nordisk, “Managing your diabetes,” httpswwwmynovoin...

Document IPR2023-00724, No. 2379 Exhibit - EX2379 Novo Nordisk, “Managing your diabetes,” httpswwwmynovoinsulincomdiabetes educationmanaging diabeteshtml, last updated Dec 2022 (P.T.A.B. Ja...

cite Cite Document

2014 Exhibit: EX2014 Weeda, E, et al, “Medication adherence to injectable glucago...

Document IPR2023-00724, No. 2014 Exhibit - EX2014 Weeda, E, et al, “Medication adherence to injectable glucagon like peptide 1 GLP 1 receptor agonists dosed once weekly vs once daily in patients wit...

cite Cite Document

2420 Exhibit: EX2420 Bydureon® BCISE™ Prescribing Information rev Oct 2017

Document IPR2023-00724, No. 2420 Exhibit - EX2420 Bydureon® BCISE™ Prescribing Information rev Oct 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2093 Exhibit: EX2093 Davies, MJ, et al, Cardiovascular outcomes trials a paradigm...

Document IPR2023-00724, No. 2093 Exhibit - EX2093 Davies, MJ, et al, Cardiovascular outcomes trials a paradigm shift in the current management of type 2 diabetes, Cardiovasc Diabetol, 21144 2022 (P...

cite Cite Document

2485 Exhibit: EX2485 US Food Drug Administration, DrugsFDA, Actos

Document IPR2023-00724, No. 2485 Exhibit - EX2485 US Food Drug Administration, DrugsFDA, Actos (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2050 Exhibit: EX2050 Declaration of Christine B Jensen, MD, PhD {REDACTED

Document IPR2023-00724, No. 2050-2 Exhibit - EX2050 Declaration of Christine B Jensen, MD, PhD {REDACTED (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2481 Exhibit: EX2481 FDA Approves Ozempic semaglutide for Cardiovascular Risk...

Document IPR2023-00724, No. 2481 Exhibit - EX2481 FDA Approves Ozempic semaglutide for Cardiovascular Risk Reduction in Adults with Type 2 Diabetes and Known Heart Disease, httpswwwdrugscom...

cite Cite Document

2078 Exhibit: EX2078 Blüher, M et al, Dose response effects on HbA1c and bodywe...

Document IPR2023-00724, No. 2078 Exhibit - EX2078 Blüher, M et al, Dose response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagonGLP 1 receptor agonist, compared with pl...

cite Cite Document

2066 Exhibit: EX2066 Kim, K, et al, “Differences in Drug Pharmacokinetics Between...

Document IPR2023-00724, No. 2066 Exhibit - EX2066 Kim, K, et al, “Differences in Drug Pharmacokinetics Between East Asians and Caucasians and the Role of Genetic Polymorphisms,” J Clin Pharmaco...

cite Cite Document

2448 Exhibit: EX2448 Xigduo® XR Prescribing Information rev July 2017

Document IPR2023-00724, No. 2448 Exhibit - EX2448 Xigduo® XR Prescribing Information rev July 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2407 Exhibit: EX2407 Victoza® Prescribing Information rev Nov 2020

Document IPR2023-00724, No. 2407 Exhibit - EX2407 Victoza® Prescribing Information rev Nov 2020 (P.T.A.B. Jan. 17, 2024)

cite Cite Document

2354 Exhibit: EX2354 Centers for Disease Control and Prevention, “Gestational Dia...

Document IPR2023-00724, No. 2354 Exhibit - EX2354 Centers for Disease Control and Prevention, “Gestational Diabetes,” httpswwwcdcgovdiabetesbasicsgestationalhtml, last reviewed Dec 30, 2022 (P....

cite Cite Document
<< 1 2 3 4 5 ... 40 41 42 43 44 ... >>